The federal government awarded an Indefinite Delivery Contract (IDC) to DR Reddy's Laboratories, Inc., a multinational pharmaceutical company, to supply Naproxen NA Tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS).
The single-award IDC has a ceiling value of $1,468,638.50 and a period of performance from February 4, 2023 to February 3, 2026, with four one-year option periods. The contract utilizes the VA and DoD Pharmaceutical Prime Vendor programs to distribute the pharmaceutical products. DR Reddy's Laboratories, which holds multiple IDCs and a Federal Supply Schedule contract with the VA, will provide an uninterrupted supply of the Naproxen NA Tablets in 275mg and 550mg strengths to support the healthcare missions of the government agencies. The contract was competitively awarded under NAICS code 325412 without any set-asides.
Generated 1/26/25, 12:01 AM